COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
作者信息
Marietta Marco, Ageno Walter, Artoni Andrea, De Candia Erica, Gresele Paolo, Marchetti Marina, Marcucci Rossella, Tripodi Armando
机构信息
Department of Oncology and Haematology, University Hospital, Modena, Italy.
Department of Medicine and Surgery, "Insubria" University, Varese, Italy.
出版信息
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
Abstract
摘要
相似文献
1
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
Blood Transfus. 2020 May;18(3):167-169. doi: 10.2450/2020.0083-20. Epub 2020 Apr 8.
2
COVID-19 coagulopathy: an evolving story.
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
3
Coagulation abnormalities and thrombosis in patients with COVID-19.
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
4
COVID-19 and thrombosis: Beyond a casual association.
Med Clin (Barc). 2020 Jul 10;155(1):44. doi: 10.1016/j.medcli.2020.04.014. Epub 2020 May 11.
5
Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation.
Semin Thromb Hemost. 2020 Oct;46(7):850-852. doi: 10.1055/s-0040-1715457. Epub 2020 Sep 4.
6
Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):758-759. doi: 10.1016/j.arbres.2020.06.013. Epub 2020 Jul 15.
7
Thromboinflammation in COVID-19 acute lung injury.
Paediatr Respir Rev. 2020 Sep;35:20-24. doi: 10.1016/j.prrv.2020.06.004. Epub 2020 Jun 11.
8
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620938149. doi: 10.1177/1076029620938149.
9
SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.
Eur J Clin Invest. 2020 Jul;50(7):e13311. doi: 10.1111/eci.13311. Epub 2020 Jun 25.
10
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Semin Thromb Hemost. 2020 Oct;46(7):785-788. doi: 10.1055/s-0040-1714275. Epub 2020 Aug 12.
引用本文的文献
1
SARS-CoV-2 Coronavirus Disease in Patients with Underlying Congenital Inferior Vena Cava Anomalies.
Biomedicines. 2025 May 29;13(6):1336. doi: 10.3390/biomedicines13061336.
2
Establishing a prediction model for lower extremity deep venous thrombosis in emergency inpatients in the post epidemic era.
Front Surg. 2025 Apr 7;12:1543860. doi: 10.3389/fsurg.2025.1543860. eCollection 2025.
3
Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers.
Metabolomics. 2024 Dec 4;21(1):3. doi: 10.1007/s11306-024-02195-y.
4
Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status.
J Pers Med. 2024 Mar 28;14(4):358. doi: 10.3390/jpm14040358.
5
Emergency laparotomy and perioperative COVID-19: a single-center retrospective cohort study.
Updates Surg. 2024 Apr;76(2):699-703. doi: 10.1007/s13304-023-01730-1. Epub 2023 Dec 26.
6
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study.
Cardiovasc Diagn Ther. 2023 Oct 31;13(5):777-791. doi: 10.21037/cdt-23-76. Epub 2023 Oct 25.
7
The role of IL-6, ferritin, and coagulopathy in Covid-19 clinical progression.
F1000Res. 2023 Sep 22;11:1285. doi: 10.12688/f1000research.125115.2. eCollection 2022.
8
A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19.
Egypt Heart J. 2023 Aug 18;75(1):72. doi: 10.1186/s43044-023-00400-2.
9
Prophylactic anticoagulants for non-hospitalised people with COVID-19.
Cochrane Database Syst Rev. 2023 Aug 16;8(8):CD015102. doi: 10.1002/14651858.CD015102.pub2.
10
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.
J Clin Lab Anal. 2023 Jun;37(11-12):e24941. doi: 10.1002/jcla.24941. Epub 2023 Jul 11.
本文引用的文献
1
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
2
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study.
BMJ. 2020 Mar 26;368:m1091. doi: 10.1136/bmj.m1091.
5
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):337-342. doi: 10.55563/clinexprheumatol/xcdary. Epub 2020 Mar 22.
6
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
7
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
8
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis.
Blood Transfus. 2020 Jul;18(4):304-311. doi: 10.2450/2019.0175-19. Epub 2019 Nov 19.
Zotero 插件